SEARCH

SEARCH BY CITATION

References

  • 1
    Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Eng J Med. 1981; 305: 11761181.
  • 2
    NKF-KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy. Am J Kidney Dis. 1997; 30(suppl 2): S15S66.
  • 3
    Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med. 2002; 347: 20102019.
  • 4
    United States Renal Data System Annual Report 2008. Available at: www.usrds.org/adr.htm. Accessed February 3, 2010.
  • 5
    Port FK, Pisoni RL, Bommer J, et al. Improving outcomes for dialysis patients in the International Dialysis Outcomes and Practice Study. Clin J Am Soc Nephrol. 2006; 1: 246255.
  • 6
    Davenport A, Cox C, Thuraisingham R. Achieving blood pressure control targets during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008; 73: 759764.
  • 7
    Aparacio M, Cano N, Chauveau P, et al. Nutritional status of haemodialysis patients: a French National Cooperative Study: French Study Group for Nutrition in Dialysis. Nephrol Dial Transplant. 1999; 14: 16791686.
  • 8
    Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in the hemodialysis patients in Europe, Japan, and the United states: the Dialysis,Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14: 32703277.
  • 9
    Kalandar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006; 70; 771780.
  • 10
    Suri RS, Garg AX, Chertow GM, et al. Frequent Hemodialysis Network (FHN) randomized trials; study design. Kidney Int. 2007; 71: 349359.
  • 11
    Gotch FA. The current place of urea kinetic modeling with respect to different dialysis modalities. Nephrol Dial Transplant. 1998; 13(suppl 6): 1014.
  • 12
    Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Beta(2)-microglobulin kinetics in nocturnal hemodialysis. Nephrol Dial Transplant. 2000; 15: 5864.
  • 13
    Fagugli RM, Vanholder RM, De Smet R, et al. Advanced glycation end products: specificfl uorescence changes of pentosidine-like compounds during short daily hemodialysis. Int J Artif Organs. 2001; 24: 256262.
  • 14
    Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs. conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007; 298: 12911299.
  • 15
    Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol. 1998; 9: 859868.
  • 16
    Pierratos A. Nocturnal home hemodialysis: an update on a 5-year experience. Nephrol Dial Transplant. 1999; 14: 28352840.
  • 17
    Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001; 38: 371376.
  • 18
    Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002; 61: 22352239.
  • 19
    Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis. 2003; 42; 1317.
  • 20
    Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study. J Nephrol. 2006; 19: 7783.
  • 21
    Chan CT, Harvey PJ, Picton P, Pierratos A, Miller JA, Floras JS. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension. 2003; 42: 925931.
  • 22
    Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism and health-related quality of life. Kidney Int. 2005; 67: 15001508.
  • 23
    McPhatter LL, Lockridge RS Jr, Albert J, et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Renal Replace Ther. 1999; 6: 358365.
  • 24
    Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003; 42: 3035.
  • 25
    Pierratos A, Ouwendyk M, Lindsay RM. Total body nitrogen increases on nocturnal hemodialysis. J Am Soc Nephrol. 1999; 10: 299A.
  • 26
    Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis. 2003; 42: 10201035.
  • 27
    Galland R, Traeger J, Arkouche W, et al. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int. 2001; 60: 15551560.
  • 28
    Galland R, Traeger J, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis. 2001; 37: S9598.
  • 29
    Yuen D, Richardson RM, Fenton SS, McGrath-Chong ME, Chan CT. Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness. ASAIO J. 2005; 51: 236241.
  • 30
    Musci I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998; 53: 13991404.
  • 31
    Toussaint N, Boddington J, Simmonds R, et al. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodialysis Int. 2006; 10: 280286.
  • 32
    Yuen D, Richardson RM, Chan CT. Improvements in phosphate control with short daily in-center hemodialysis. Clin Nephrol. 2005; 64: 364370.
  • 33
    Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting “daily” hemodialysis. Kidney Int. 1999; 55: 24672476.
  • 34
    Schwartz DI, Pierratos A, Richardson RM, Fenton SS, Chan CT. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol. 2005; 63: 202208.
  • 35
    Perl J, Unruh ML, Chan CT. Sleep disorders in end-stage renal disease: markers of inadequate dialysis? Kidney Int. 2006; 70: 16871693.
  • 36
    Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med. 2001; 344: 102107.
  • 37
    Chan CT, Hanly P, Gabor J, et al. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int. 2004; 65: 661665.
  • 38
    Mohr PE, Neumann PJ, Franco SJ, et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis. 2001; 37: 777789.
  • 39
    Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int. 2009; 75: 542549.
  • 40
    Fong E, Bargman JM, Chan CT. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis. Clin J Am Soc Nephrol. 2007; 2: 11951200.
  • 41
    McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int. 2003; 64: 10041011.
  • 42
    Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian home hemodialysis. Am J Kidney Dis. 2003; 42: 3641.
  • 43
    Bergman A, Fenton SS, Richardson RM, Chan CT. Reduction in cardiovascular-related hospitalization with nocturnal home hemodialysis. Clin Nephrol. 2008; 69: 3339.
  • 44
    Komenda P, Sood MM. The economics of home dialysis: acting for the individual while planning responsibly for the population. Adv Chronic Kidney Dis. 2009; 16: 198204.
  • 45
    Kjellatrand CM, Buonocristiani U, Ting G, et al. Short daily hemodialysis: survival in 415 patients treated for 1,006 patient-years. Nephrol Dial Transplant. 2008; 23: 32833289.
  • 46
    Marshall MR, Kerr PG, Disney AP, et al. Home hemodialysis (HHD) is associated with lower mortality than facility hemodialysis (FHD) in Australian and New Zealand populations. J Am Soc Nephrol. 2008; 19: 72A.
  • 47
    Ok E, Duman S, Asci G, et al. Eight-hour nocturnal in-center hemodialysis provides survival benefit over four-hour conventional hemodialysis. J Am Soc Nephrol. 2008; 19: 71A.
  • 48
    Pauly RP. Nocturnal home hemodialysis and short daily hemodialysis compared with kidney transplantation: emerging data in a new era. Adv Chronic Kidney Dis. 2009; 16: 169172.
  • 49
    Pauly RP, Gill JS, Rose CL, et al. Survival among nocturnal home hemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant. 2009; 24: 29152919.
  • 50
    McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int. 2002; 62: 22162222.
  • 51
    Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis. 2003; 42: 4955.